rna
virus
amongst
versatil
complic
pathogen
term
genet
materi
evolut
mode
transmiss
variou
host
persist
environ
divers
genom
architectur
replic
strategi
error
prone
rna
polymeras
drive
viru
evolut
unpreced
rate
viral
genom
thrive
quasispeci
continu
adapt
respons
host
environ
vignuzzi
et
al
rna
virus
exhibit
broad
host
tropism
known
highest
propens
cross
speci
barrier
geoghegan
et
al
expand
host
rang
facilit
emerg
new
viru
type
caus
new
diseas
potenti
occur
outbreak
epidem
vector
anim
carrier
ensur
persist
endem
mani
rna
virus
tropic
subtrop
region
world
despit
high
diseas
burden
low
middleincom
countri
lmic
includ
india
invest
enough
research
develop
rna
virus
littl
inform
epidemiolog
diseas
burden
risk
factor
immun
respons
virus
divers
human
anim
popul
india
symposium
rna
virus
immunolog
pathogenesi
translat
opportun
fund
european
molecular
biolog
organ
wellcom
biotechnolog
india
allianc
organ
faridabad
nation
capit
region
india
march
http
symposium
host
nation
intern
speaker
chair
particip
divers
research
area
virolog
bioinformat
immunolog
clinic
research
cell
molecular
biolog
epidemiolog
diagnost
clinic
research
pleas
see
meet
program
supplementari
inform
interact
session
panel
discuss
held
critic
analyz
statu
rna
viru
research
india
challeng
initi
translat
research
program
explor
way
forward
articl
present
outcom
discuss
could
act
relev
inform
fund
agenc
institut
leader
polici
maker
india
global
popul
live
arbovirusendem
zone
risk
exposur
dengu
viru
denv
zika
viru
zikv
chikungunya
viru
chikv
yellow
fever
viru
yfv
andor
japanes
enceph
viru
jev
denv
alon
caus
around
million
appar
case
everi
year
stanaway
et
al
zikv
remerg
south
america
recent
report
indic
chang
genom
render
current
circul
strain
virul
yuan
et
al
singl
mutat
chikv
envelop
enabl
replic
new
vector
aed
albopictu
thu
increas
geograph
rang
tsetsarkin
et
al
enter
rna
virus
rotaviru
noroviru
continu
major
etiolog
agent
childhood
diarrhea
case
mild
sever
respiratori
ill
rna
virus
respiratori
syncyti
viru
rsv
lead
caus
sever
pneumonia
children
year
age
close
million
infect
shi
et
al
annual
epidem
influenza
pandem
potenti
influenza
virus
remain
constant
threat
addit
virus
ebola
viru
crimeancongo
haemorrhag
fever
viru
cchfv
middl
east
respiratori
syndrom
coronaviru
merscov
potenti
lead
outbreak
burden
viral
infect
either
estim
thoroughli
consist
huge
underestim
india
denv
alon
estim
cost
around
billion
term
annual
econom
burden
shepard
et
al
real
estim
infect
caus
rna
virus
chikungunya
influenza
respiratori
enter
rna
virus
emerg
rna
virus
zikv
nipah
viru
chandipura
viru
cchfv
also
matter
grave
concern
india
tropic
weather
condit
poor
sanit
person
hygien
dens
popul
lack
prophylact
therapeut
option
primarili
contribut
yearround
outbreak
establish
endem
mani
rna
virus
mani
report
indic
widespread
coinfect
true
impact
coinfect
across
age
group
remain
determin
india
rank
fifth
global
research
public
output
vaccin
research
develop
india
make
steadi
progress
evid
number
product
licensur
last
year
candid
vaccin
develop
bhandari
et
al
singh
et
al
dubey
et
al
kulkarni
et
al
b
sutton
et
al
ramasami
et
al
india
produc
world
vaccin
member
govern
council
intern
vaccin
institut
commit
us
everi
year
biotechnolog
industri
research
assist
council
birac
depart
biotechnolog
start
mani
initi
support
research
program
new
vaccin
mani
new
program
birac
nurtur
industryacademia
partnership
similarli
increas
invest
indian
council
medic
research
depart
scienc
technolog
signific
impact
direct
last
year
seen
establish
number
world
class
educ
research
institut
indian
institut
scienc
educ
research
iiser
translat
health
scienc
technolog
institut
nation
institut
biomed
genom
nation
institut
anim
biotechnolog
addit
sever
new
india
institut
medic
scienc
indian
institut
technolog
therefor
time
apt
creat
roadmap
research
infecti
diseas
caus
rna
virus
india
challeng
rna
viru
research
india
manifold
bottleneck
elabor
section
could
also
relev
lmic
compar
western
countri
develop
countri
like
india
sluggish
build
consortia
translat
research
establish
translat
research
institut
fund
translat
research
program
although
young
indian
institut
research
develop
research
program
translat
outcom
mind
need
build
enabl
ecosystem
exampl
elucid
figur
translat
research
program
virolog
antivir
vaccin
develop
outcom
would
requir
welldesign
sustain
partnership
ration
design
optim
develop
immunogen
base
knowledg
epitop
involv
viral
entri
molecular
interact
antigen
gener
definit
knowledg
immun
respons
confer
protect
vs
robust
assay
platform
valid
refer
reagent
diagnosi
surveil
molecular
epidemiolog
immun
reliabl
estim
diseas
burden
welldesign
surveil
deliveri
platform
determin
breadth
longev
immun
robust
manufactur
partner
lowcost
manufactur
capabl
compli
gmp
norm
technic
knowhow
scale
stabl
clinic
trial
partner
thorough
knowledg
regulatori
requir
start
phase
postlicensur
activ
case
point
develop
novel
indigen
vaccin
candid
dengu
ramasami
et
al
began
assum
safeti
immunogen
phase
iii
trial
result
like
announc
later
similarli
work
began
structureguid
ration
design
candid
influenza
vaccin
focus
steadi
progress
led
complet
proofofconcept
studi
anim
recent
bommakanti
et
al
mallajosyula
et
al
sutton
et
al
hand
develop
classic
rotaviru
vaccin
start
observ
could
accomplish
larg
intern
consortium
work
togeth
three
decad
bhandari
et
al
thu
enabl
translat
research
gener
requir
concert
effort
sustain
fund
institut
support
therefor
institut
fund
agenc
need
redesign
evalu
input
mechan
project
translat
outcom
end
point
huge
challeng
invest
involv
larg
shortterm
outcom
guarante
success
group
expert
indiaembo
symposium
rna
virus
debat
recogn
challeng
run
sustain
translat
program
india
lmic
group
also
felt
india
uniqu
capabl
resourc
address
challeng
set
exampl
resourceconstrain
nation
expert
panel
particip
discuss
variou
problem
suggest
follow
practic
solut
could
implement
go
forward
world
today
singl
tribe
viral
infect
need
view
global
region
nation
perspect
exampl
sever
acut
respiratori
syndrom
sar
chikungunya
zika
shown
us
viral
infect
local
today
global
tomorrow
combat
viral
infect
outbreak
therefor
requir
truli
global
effort
commun
scientist
concern
profession
must
work
togeth
singl
minded
prevent
human
suffer
must
build
capac
capabl
lmic
often
vulner
viral
infecti
diseas
outbreak
epidem
india
taken
posit
step
partner
coalit
epidem
prepared
innov
cepi
anchor
key
program
prepar
india
emerg
virus
fund
agenc
believ
philosophi
sustain
invest
knowledg
activ
involv
exchang
idea
research
leadership
institut
fund
agenc
lend
coher
scientif
enterpris
provid
better
direct
util
exist
resourc
believ
effort
enhanc
india
contribut
knowledg
gener
innov
global
rna
viru
research
arena
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
